MariMed Inc.CSE: MRMD

MariMed Submits DEA Registration Applications For State-Licensed Medical Cannabis Businesses

· Issued by MariMed Inc. via GlobeNewswire

Summary by 6ix AI

MariMed Inc., a multi-state cannabis operator, said on June 25, 2026 that it has submitted applications to the U.S. Drug Enforcement Agency (DEA) to register certain of its state-licensed medical cannabis operations.

Key details

  • MariMed says registering its medical cannabis licenses with the DEA is required to qualify for protections from the federal rescheduling of medical marijuana to Schedule III, a drug category under the federal Controlled Substances Act.
  • The applications cover certain of the company's state-licensed medical cannabis operations, not all of its businesses.

What’s still pending

  • The applications have been submitted, and DEA registration is still pending.

6ix AI wrote this summary from the release below and checked it against the release.

NORWOOD, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator, today announced the Company has submitted applications with the U.S. Drug Enforcement Agency (“DEA”) to register certain state-licensed medical cannabis operations. Registering the Company’s medical cannabis licenses with the DEA is a requirement to qualify for protections provided by the federal rescheduling of medical marijuana to Schedule III of the Controlled Substances Act.

“DEA registration of certain of our medical businesses marks an important step forward for MariMed as we move the Company toward becoming a federally legal business,” said MariMed CEO Jon Levine.

About MariMed
MariMed Inc. is a leading multi-state cannabis operator, known for developing and managing state-of-the-art cultivation, production, and retail facilities. Our award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby’s Baked™, Vibations™, InHouse™, and Nature’s Heritage™, sets us apart as an industry leader. These trusted brands, crafted with quality and innovation, are recognized and loved by consumers across the country. With a commitment to excellence, MariMed continues to drive growth and set new standards in the cannabis industry. For additional information, visit www.marimedinc.com.

Company Contact:
Howard Schacter
Chief Communications Officer
Email: hschacter@marimedinc.com
Phone: (781) 277-0007

Primary Logo

MariMed Inc. on 6ix

Earlier from MariMed

Later from MariMed

All MariMed news releases